Novartis Pharmaceuticals Corporation

Breaking News

Reported tornado causes damage in Great Valley

June 10, 2025

GREAT VALLEY — Another wave of severe storms passed through the area Monday evening, with a reported tornado causing significant damage to homes and o...

Press Releases

Novartis receives FDA accelerated approval for Vanrafia® (atrasentan), the first and only selective endothelin A receptor antagonist for proteinuria reduction in primary IgA nephropathy (IgAN)

Novartis Pharmaceuticals Corporation

April 3, 2025

EAST HANOVER, N.J. , April 2, 2025 /PRNewswire/ -- Novartis today announced the US Food and Drug Administration (FDA) has granted accelerated approval...

Press Releases

Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G)

Novartis Pharmaceuticals Corporation

March 20, 2025

EAST HANOVER, N.J. , March 20, 2025 /PRNewswire/ -- Novartis today announced that oral Fabhalta ® (iptacopan) has received U.S. Food and Drug Administ...

Press Releases

Novartis data presentations at AAAAI and AAD underscore commitment to advancing treatment of hidradenitis suppurativa (HS) and chronic spontaneous urticaria (CSU)

Novartis Pharmaceuticals Corporation

February 28, 2025

EAST HANOVER, N.J. , Feb. 28, 2025 /PRNewswire/ -- Novartis announced today it will present data from 17 abstracts, including investigator-initiated t...

Press Releases

Early detection is a game changer: Novartis makes bold play to prioritize breast health and inspire a new wave of breast cancer screenings

Novartis Pharmaceuticals Corporation

January 28, 2025

EAST HANOVER, N.J. , Jan. 28, 2025 /PRNewswire/ -- Novartis, a global leader in breast cancer care, today announced the launch of the "Your Attention,...

Salamanca Press

Get in touch with The Salamanca Press

Submit Content

Advertise

Subscribe